Windlas Biotech Limited (BOM:543329)

Windlas Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	5.35	4.24	52.88	36.86	5.7
Short-Term Investments	-	99.13	154.81	256.39	217.68	1,106
Trading Asset Securities	-	2,684	2,234	1,734	1,065	648.24
Cash & Short-Term Investments	2,788	2,788	2,393	2,044	1,320	1,760
Cash Growth	16.53%	16.53%	17.08%	54.86%	-25.03%	224.44%
Accounts Receivable	-	2,274	1,669	1,363	1,169	1,108
Other Receivables	-	4.3	38.64	6.66	4.38	22.13
Receivables	-	2,278	1,707	1,369	1,173	1,130
Inventory	-	618.24	813.84	621.89	747.38	587.1
Prepaid Expenses	-	13.94	10.54	9.84	8.71	9.54
Other Current Assets	-	569.83	329.88	268.08	286.61	329.76
Total Current Assets	-	6,269	5,254	4,313	3,535	3,817
Property, Plant & Equipment	-	2,660	2,219	1,803	1,227	983.15
Long-Term Investments	-	-	0.5	16.38	52.44	25.61
Other Intangible Assets	-	69.11	67.79	44.68	14.84	8.82
Long-Term Deferred Tax Assets	-	4.48	2.83	5.72	20.25	20.35
Other Long-Term Assets	-	71.32	59.84	79.54	439.85	55.67
Total Assets	-	9,073	7,605	6,262	5,290	4,910

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	2,385	1,778	1,315	877.43	632.32
Accrued Expenses	-	369.94	284.71	336.36	282.13	228.55
Short-Term Debt	-	-	-	-	-	53.13
Current Portion of Long-Term Debt	-	298.75	271.17	1.09	3.35	3.64
Current Portion of Leases	-	32.19	32.29	15.14	15.32	5.16
Current Income Taxes Payable	-	22.92	-	-	5.91	-
Other Current Liabilities	-	100.57	127.87	49.81	28.28	17.06
Total Current Liabilities	-	3,209	2,494	1,718	1,212	939.86
Long-Term Debt	-	-	-	-	1.09	4.44
Long-Term Leases	-	21.48	22.51	20.18	30.17	-
Other Long-Term Liabilities	-	34.32	29.84	25.01	23.36	18.03
Total Liabilities	-	3,265	2,547	1,763	1,267	962.33

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	105.53	104.8	103.99	104.63	108.97
Additional Paid-In Capital	-	2,029	1,989	1,946	1,986	2,269
Retained Earnings	-	3,473	2,907	2,396	1,900	1,551
Comprehensive Income & Other	-	201.14	56.99	53.45	32.19	18.04
Total Common Equity	5,808	5,808	5,058	4,499	4,023	3,948
Shareholders' Equity	5,808	5,808	5,058	4,499	4,023	3,948
Total Liabilities & Equity	-	9,073	7,605	6,262	5,290	4,910

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	352.42	352.42	325.97	36.41	49.93	66.37
Net Cash (Debt)	2,436	2,436	2,067	2,007	1,270	1,694
Net Cash Growth	17.85%	17.85%	2.97%	58.08%	-25.04%	673.25%
Net Cash Per Share	114.13	114.17	97.82	96.16	58.69	82.64
Filing Date Shares Outstanding	20.64	20.64	20.96	20.8	20.95	21.79
Total Common Shares Outstanding	20.64	21.11	20.96	20.8	20.95	21.79
Working Capital	-	3,059	2,760	2,595	2,323	2,877
Book Value Per Share	275.20	275.20	241.31	216.33	192.05	181.14
Tangible Book Value	5,739	5,739	4,990	4,455	4,008	3,939
Tangible Book Value Per Share	271.92	271.92	238.08	214.18	191.34	180.73
Land	-	313.59	313.59	313.59	313.59	215.71
Buildings	-	811.97	807.45	637.58	489.59	453.6
Machinery	-	2,150	1,970	1,639	1,005	890.46
Construction In Progress	-	561.55	32.01	57.08	138.01	75.81

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error